Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1982 3
1983 1
1984 2
1985 1
1986 2
1987 5
1988 4
1989 11
1990 12
1991 9
1992 15
1993 15
1994 19
1995 22
1996 32
1997 35
1998 29
1999 30
2000 30
2001 39
2002 39
2003 36
2004 39
2005 47
2006 51
2007 49
2008 88
2009 66
2010 63
2011 86
2012 101
2013 125
2014 150
2015 159
2016 142
2017 140
2018 111
2019 138
2020 149
2021 150
2022 147
2023 123
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

2,151 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 3 Clear Cell Renal Cell Carcinoma"
Page 1
Grading of renal cell carcinoma.
Delahunt B, Eble JN, Egevad L, Samaratunga H. Delahunt B, et al. Histopathology. 2019 Jan;74(1):4-17. doi: 10.1111/his.13735. Histopathology. 2019. PMID: 30565310 Review.
Grading of renal cell carcinoma (RCC) has been recognised as a prognostic factor for almost 100 years. ...This grading system has been validated for both clear cell and papillary RCC. ...
Grading of renal cell carcinoma (RCC) has been recognised as a prognostic factor for almost 100 years. ...This
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee CH, Voss MH, Carlo MI, Chen YB, Zucker M, Knezevic A, Lefkowitz RA, Shapnik N, Dadoun C, Reznik E, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha R, Feldman DR, Motzer RJ. Lee CH, et al. J Clin Oncol. 2022 Jul 20;40(21):2333-2341. doi: 10.1200/JCO.21.01944. Epub 2022 Mar 17. J Clin Oncol. 2022. PMID: 35298296 Free PMC article. Clinical Trial.
PURPOSE: To assess the efficacy and safety of cabozantinib plus nivolumab in a phase II trial in patients with non-clear-cell renal cell carcinoma (RCC). PATIENTS AND METHODS: Patients had advanced non-clear-cell renal ca
PURPOSE: To assess the efficacy and safety of cabozantinib plus nivolumab in a phase II trial in patients with non-clear-cell
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP, Chen YH, Zhao HW, Cao JZ, Liu TJ, Xiong SW, Yu YF, Liao B, Cao Y, Li JY, Huang KB, Han H, Zhang ZL, Chen WF, Jiang ZY, Gao Y, Han GP, Tang Q, Ouyang K, Qu GM, Wu JT, Guo JP, Li CX, Li PX, Liu ZP, Hsieh JT, Cai MY, Li XS, Wei JH, Luo JH. Gui CP, et al. Lancet Digit Health. 2023 Aug;5(8):e515-e524. doi: 10.1016/S2589-7500(23)00095-X. Epub 2023 Jun 29. Lancet Digit Health. 2023. PMID: 37393162 Free article.
BACKGROUND: Improved markers for predicting recurrence are needed to stratify patients with localised (stage I-III) renal cell carcinoma after surgery for selection of adjuvant therapy. ...INTERPRETATION: Our multimodal recurrence score is a pra …
BACKGROUND: Improved markers for predicting recurrence are needed to stratify patients with localised (stage I-III) renal c
Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma.
Chen S, Jiang L, Gao F, Zhang E, Wang T, Zhang N, Wang X, Zheng J. Chen S, et al. Br J Cancer. 2022 Mar;126(5):771-777. doi: 10.1038/s41416-021-01640-2. Epub 2021 Nov 25. Br J Cancer. 2022. PMID: 34824449 Free PMC article.
BACKGROUND: Traditional histopathology performed by pathologists through naked eyes is insufficient for accurate survival prediction of clear cell renal cell carcinoma (ccRCC). METHODS: A total of 483 whole slide images (WSIs) data from t …
BACKGROUND: Traditional histopathology performed by pathologists through naked eyes is insufficient for accurate survival prediction
Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study.
Liu DH, Dani KA, Reddy SS, Lei X, Demirjian NL, Hwang DH, Varghese BA, Rhie SK, Yap FY, Quinn DI, Siddiqi I, Aron M, Vaishampayan U, Zahoor H, Cen SY, Gill IS, Duddalwar VA. Liu DH, et al. Oncology. 2023;101(6):375-388. doi: 10.1159/000530719. Epub 2023 Apr 20. Oncology. 2023. PMID: 37080171 Free article.
INTRODUCTION: This study investigates how quantitative texture analysis can be used to non-invasively identify novel radiogenomic correlations with clear cell renal cell carcinoma (ccRCC) biomarkers. METHODS: The Cancer Genome Atlas-Kidney Re
INTRODUCTION: This study investigates how quantitative texture analysis can be used to non-invasively identify novel radiogenomic correlatio …
Gleason and Fuhrman no longer make the grade.
Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR. Delahunt B, et al. Histopathology. 2016 Mar;68(4):475-81. doi: 10.1111/his.12803. Epub 2015 Nov 16. Histopathology. 2016. PMID: 26266664 Review.
In 2005 and 2014, the International Society of Urological Pathology (ISUP) proposed changes to Gleason scoring with the adoption of the ISUP grading for prostate cancer in 2014 (grade 1, score 3 + 3; grade 2, score 3 + 4; …
In 2005 and 2014, the International Society of Urological Pathology (ISUP) proposed changes to Gleason scoring with the adoption of the ISUP …
Outcome prediction for patients with renal cell carcinoma.
Lohse CM, Gupta S, Cheville JC. Lohse CM, et al. Semin Diagn Pathol. 2015 Mar;32(2):172-83. doi: 10.1053/j.semdp.2015.02.008. Epub 2015 Feb 7. Semin Diagn Pathol. 2015. PMID: 25753528 Review.
Outcome assessment for renal cell carcinoma is somewhat controversial. Despite numerous studies, a very limited variety of features have been recognized as having prognostic significance in clinical practice. In this review, tumor features considered to be of …
Outcome assessment for renal cell carcinoma is somewhat controversial. Despite numerous studies, a very limited variety …
A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study.
Nie P, Yang G, Wang Y, Xu Y, Yan L, Zhang M, Zhao L, Wang N, Zhao X, Li X, Cheng N, Wang Y, Chen C, Wang N, Duan S, Wang X, Wang Z. Nie P, et al. Eur Radiol. 2023 Dec;33(12):8858-8868. doi: 10.1007/s00330-023-09869-6. Epub 2023 Jun 30. Eur Radiol. 2023. PMID: 37389608
OBJECTIVES: To develop and validate a CT-based deep learning radiomics nomogram (DLRN) for outcome prediction in clear cell renal cell carcinoma (ccRCC), and its performance was compared with the Stage, Size, Grade, and Necrosis (S …
OBJECTIVES: To develop and validate a CT-based deep learning radiomics nomogram (DLRN) for outcome prediction in clear cell
Expression Of Bap1 In Clear Cell Renal Cell Carcinoma.
Fatima A, Mushtaq S, Loya A, Hassan U, Sheikh UN. Fatima A, et al. J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):283-287. doi: 10.55519/JAMC-02-9313. J Ayub Med Coll Abbottabad. 2022. PMID: 35576287 Free article.
BACKGROUND: BAP1 (BRCA1 associated protein 1 on chromosome 3) is a commonly mutated gene in clear cell renal cell carcinoma. ...Immunohistochemistry was used to evaluate the loss of nuclear expression of BAP1. RESULTS: Loss of BAP1 was …
BACKGROUND: BAP1 (BRCA1 associated protein 1 on chromosome 3) is a commonly mutated gene in clear cell renal
Automated clear cell renal carcinoma grade classification with prognostic significance.
Tian K, Rubadue CA, Lin DI, Veta M, Pyle ME, Irshad H, Heng YJ. Tian K, et al. PLoS One. 2019 Oct 3;14(10):e0222641. doi: 10.1371/journal.pone.0222641. eCollection 2019. PLoS One. 2019. PMID: 31581201 Free PMC article.
We developed an automated 2-tiered Fuhrman's grading system for clear cell renal cell carcinoma (ccRCC). Whole slide images (WSI) and clinical data were retrieved for 395 The Cancer Genome Atlas (TCGA) ccRCC cases. ...In the extended test …
We developed an automated 2-tiered Fuhrman's grading system for clear cell renal cell carcinoma (c …
2,151 results